Edition: 
1st

Guide to Cancer Immunotherapy

0
No votes yet

Recent advances in immunotherapy have revolutionized treatment delivery and toxicity management in cancer care. Oncology nurses are at the forefront of prevention and management of immune-mediated toxicities and leaders in patient education in this rapidly evolving field. Guide to Cancer Immunotherapy was developed by an expert collection of healthcare professionals and nursing leaders to provide nurses with in-depth knowledge on the principles of immunology, cancer and the immune system, and the history of immunotherapy. This foundational work is supported with information on the development of new agents and classes of agents, active immunization, passive/adoptive immunotherapy, combination therapies, biomarkers, and many other topics. As more is discovered about these powerful treatments, this comprehensive reference will serve as a lasting tool for the management of toxicities and the treatment of additional malignancies.

 

Member Price: $44.00Nonmember Price: $69.95
ISBN: 
9781635930184
Published By: 
Oncology Nursing Society
Publication Date: 
2018
Pages: 
336

Chapters

Chapter 3 - Cytokines in Immunotherapy

Brianna Hoffner
Chapter 3 details cytokines in immunotherapy. The chapter provides examples of types of cytokines, including Interferon Alfa, Interleukin-2, Interleukin-6, and Granulocyte Macrophage–Colony-Stimulating Factor, as well as information on cytokines and...

Chapter 4 - Immune Checkpoint Inhibitors

Victoria Sherry
Susan Stonehouse-Lee
Chapter 4 examines immune checkpoint inhibitors, including checkpoint receptors such as Cytotoxic T-lymphocyte Antigen 4 and programmed cell death protein 1 and its ligands, and checkpoint inhibitors such as anti–CTLA-4 agents and anti–PD-1 agents. Also...

Chapter 6 - Oral Immunomodulatory Agents

Kevin Brigle
Chapter 6 provides details and background on oral immunomodulatory agents, including the history, mechanism of action, risk evaluation and mitigation strategy, clinical applications, and nursing implications. Agents detailed include Thalidomide,...

Chapter 7 - Active Immunity: Vaccine Therapy

Kristine Deano Abueg
Chapter 7 details issues surrounding vaccine therapy and active immunity, describing how immunity is developed through vaccines and considerations in vaccine development. Agents detailed include Sipuleucel-T and Talimogene Laherparepvec.

Chapter 8 - Passive/Adoptive Immunotherapy

Barbara Barnes Rogers
Chapter 8 details passive/adoptive immunotherapy, including information on tumor-targeting monoclonal antibodies and epidermal growth factor receptor–specific monoclonal antibodies, as well as common side effects associated with both passive and adoptive...

Chapter 9 - Combination Therapies

Lisa Kottschade
Chapter 9 examines combination therapies, including chemoimmunotherapy and biochemotherapy, radioimmunotherapy, and combination immunotherapy.